Literature DB >> 32461467

Rubella retinopathy with choroidal neovascular membrane in a 7-year-old.

Lubhavni Dewan1, Nasiq Hasan1, Neelima Aron1, Rohan Chawla1, Dheepak Sundar1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32461467      PMCID: PMC7508066          DOI: 10.4103/ijo.IJO_1469_19

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
A 7-year-old girl with rubella retinopathy, sensorineural hearing loss and cardiac defects presented to our center with a decrease in vision in the right eye (RE) for 8 months. On examination, visual acuity in OD was 1/60 and in OS was 6/6. On fundus examination, the RE revealed a grey lesion at macula with pigmentary changes suggestive of a choroidal neovascular membrane along with salt and pepper retinopathy [Fig. 1a and b]. Fundus autofluorescence (FAF) [Fig. 1c] was suggestive of RPE atrophy, and SS-OCT of the macula revealed a spindle-shaped thickened hyperreflective area above the retinal pigment epithelium adjacent to fovea along with thinning and loss of outer retinal layers [Fig. 1d], suggestive of a long-standing membrane with resultant foveal atrophy. The left eye (LE) showed salt and pepper retinopathy with a dull foveal reflex.
Figure 1

Right eye (OD). (a) Ultra-wide field pseudo-color fundus photograph shows salt and pepper pigmentary changes. (b) Clinical photograph of the macula showing a choroidal neovascular membrane with surrounding pigmentary changes and areas of hemorrhage. (c) Ultra-wide field FAF image showing hypoautofluorescent area indicative of RPE atrophy with a surrounding rim of hyper autofluorescence inferiorly indicating viable pigment epithelial cells. (d) SSOCT showing foveal atrophy with type 2 CNV complex (predominantly inactive). The Cone outer segment tips and Ellipsoid zone are also disrupted

Right eye (OD). (a) Ultra-wide field pseudo-color fundus photograph shows salt and pepper pigmentary changes. (b) Clinical photograph of the macula showing a choroidal neovascular membrane with surrounding pigmentary changes and areas of hemorrhage. (c) Ultra-wide field FAF image showing hypoautofluorescent area indicative of RPE atrophy with a surrounding rim of hyper autofluorescence inferiorly indicating viable pigment epithelial cells. (d) SSOCT showing foveal atrophy with type 2 CNV complex (predominantly inactive). The Cone outer segment tips and Ellipsoid zone are also disrupted Cases of congenital rubella commonly present to the ophthalmology department with cataract, microphthalmos, glaucoma, or pigmentary retinopathy.[1] Vision loss is commonly due to cataract or coexistent microphthalmos and nystagmus.[2] Pigmentary retinopathy per se does not usually lead to visual loss. Choroidal neovascularization associated with pigmentary retinopathy due to chronic atrophy of the retinal layers at the macula leads to vision loss.[3] Kiziltoprak et al. has injected intravitreal aflibercept in a case of CNV associated with rubella retinopathy and found significant improvement in visual acuity with a single injection.[4] In our case, foveal atrophy had already set in and the CNV had regressed to form a scar by course of time hence guarded prognosis was explained to the parents and they were counseled regarding not going ahead with any treatment for the same.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Intravitreal aflibercept for the treatment of choroidal neovascularization associated with rubella retinopathy.

Authors:  Hasan Kiziltoprak; Esat Yetkin; Kemal Tekin; Mustafa Koc; İrfan Akalin; Mehmet Yasin Teke
Journal:  Int Ophthalmol       Date:  2018-02-06       Impact factor: 2.031

2.  Rubella retinopathy and subretinal neovascularization.

Authors:  A F Deutman; W S Grizzard
Journal:  Am J Ophthalmol       Date:  1978-01       Impact factor: 5.258

3.  Rubella maculopathy.

Authors:  D H Orth; G A Fishman; M Segall; A Bhatt; Y Yassur
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638

4.  Subretinal neovascularization following rubella retinopathy.

Authors:  K E Frank; E W Purnell
Journal:  Am J Ophthalmol       Date:  1978-10       Impact factor: 5.258

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.